Neuphoria Therapeutics Inc. NEUP
NASDAQ · United States · Health Technology
$3.50-0.01 (-0.28%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q4 2026 | 2026-09-18 | 0.26 | -0.56 | +146.4% | $0 | — | -0.1%$3.71→$3.71 |
| Q3 2026 | 2026-05-15 | -0.09 | -0.56 | +83.9% | — | — | -7.3%$5.09→$4.72 |
| Q2 2026 | 2026-02-17 | 0.41 | -0.56 | +173.2% | — | — | +9.1%$4.05→$4.42 |
| Q3 2025 | 2025-11-14 | -4.41 | -0.55 | -701.8% | — | — | -1.1%$4.75→$4.70 |
| Q4 2025 | 2025-09-29 | -5.55 | -3.83 | -44.9% | — | — | — |
| Q3 2025 | 2025-05-20 | 6.55 | 6.44 | +1.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.